Analyst price target range
Neurogene Price Target: $80.43 Average
Direct answer
Neurogene's average price target is $80.43.
The verified analyst range runs from $46.00 to $166.00.
The low target implies +50.8%, the high target implies +444.1%, and the range spans 393.3% of the current price.
Forecast evidence checked September 23, 2026.
Get free Neurogene email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $30.51
- Average price target
- $80.43
- High price target
- $166.00
- Low price target
- $46.00
- Low target gap
- +50.8%
- Target upside
- +163.6%
- High target gap
- +444.1%
- Target range width
- 393.3%
- Consensus rating
- none
- Analysts
- 7
- Evidence date
- September 23, 2026
- Valid through
- September 30, 2026
Explore related company data
Read the frequently asked questions.
What is Neurogene's average price target?
Neurogene's verified average price target is $80.43. The target range is $46.00 to $166.00.
How far are Neurogene's low and high targets from the recorded price?
The low target implies +50.8%, while the high target implies +444.1%.
How many analysts are included in Neurogene's consensus?
The verified consensus includes 7 analysts.
How is Neurogene's target upside or downside calculated?
The average target of $80.43 is divided by the recorded price of $30.51, then one is subtracted to produce +163.6%. This does not guarantee a future return.
When was Neurogene's analyst forecast verified?
The data was verified on 2026-09-23. The dataset is valid through 2026-09-30.